Serum tumor marker levels at diagnosis were CEA 13.7 ng/ml; CYFRA 26.6 ng/ml; pro‐GRP 67.0 pg/ml and NSE 18.4 ng/ml. This evidence concerns the gene CEACAM5 and neoplasm.